Brief: Centessa Announces Pricing Of Initial Public Offering
May 27 (Reuters) - Centessa Pharmaceuticals PLC CNTA.O :
* CENTESSA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
* CENTESSA PHARMACEUTICALS - PRICING OF ITS IPO OF
16,500,000
AMERICAN DEPOSITARY SHARES, EACH REPRESENTING ONE ORDINARY SHARE
AT $20.00 PER ADS
* CENTESSA PHARMACEUTICALS - SHARES ARE EXPECTED TO BEGIN
TRADING
ON NASDAQ GLOBAL SELECT MARKET UNDER TICKER SYMBOL "CNTA" ON MAY
28, 2021
Source text for Eikon: ID:nBwc4wCFa
Further company coverage: CNTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1